Loxo Oncology, Inc. Contract Liability (Deferred Revenue)
Loxo Oncology, Inc. had Contract Liability (Deferred Revenue) of $125.44 million as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2018-11-08
- 2018-09-30: Contract with Customer, Liability, Current $125.44M.
- 2018-06-30: Contract with Customer, Liability, Current $146.14M.
- 2018-03-31: Contract with Customer, Liability, Current $176.16M.
- 2017-12-31: Contract with Customer, Liability, Current $195.04M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2018-09-30 | $125.44M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $146.14M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $176.16M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $195.04M 10-Q · filed 2018-11-08 |